Intranasal vaccination with a Newcastle disease virus-vectored vaccine protects hamsters from SARS-CoV-2 infection and disease

被引：22

作者：

Warner, Bryce M. ^{[1
]}

Santry, Lisa A. ^{[2
]}

Leacy, Alexander ^{[2
]}

Chan, Mable ^{[1
]}

Pham, Phuc H. ^{[2
]}

Vendramelli, Robert ^{[1
]}

Pei, Yanlong ^{[2
]}

Tailor, Nikesh ^{[1
]}

Valcourt, Emelissa ^{[1
]}

Leung, Anders ^{[1
]}

He, Shihua ^{[1
]}

Griffin, Bryan D. ^{[1
]}

Audet, Jonathan ^{[1
]}

Willman, Marnie ^{[3
]}

Tierney, Kevin ^{[1
]}

Albietz, Alixandra ^{[1
]}

Frost, Kathy L. ^{[1
]}

Yates, Jacob G. E. ^{[2
]}

Mould, Robert C. ^{[2
]}

Chan, Lily ^{[2
]}

Mehrani, Yeganeh ^{[2
]}

Knapp, Jason P. ^{[2
]}

Minott, Jessica A. ^{[2
]}

Banadyga, Logan ^{[1
]}

Safronetz, David ^{[1
,3
]}

Wood, Heidi ^{[1
]}

Booth, Stephanie ^{[1
]}

Major, Pierre P. ^{[4
]}

Bridle, Byram W. ^{[2
]}

Susta, Leonardo ^{[2
]}

Kobasa, Darwyn ^{[1
,3
]}

Wootton, Sarah K. ^{[2
]}

机构：

[1] Publ Hlth Agcy Canada, Zoonot Dis & Special Pathogens, Winnipeg, MB, Canada

[2] Univ Guelph, Dept Pathobiol, Guelph, ON, Canada

[3] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada

[4] Juravinski Canc Ctr, 699 Concess St, Hamilton, ON L8V 5C2, Canada

来源：

ISCIENCE | 2021年 / 24卷 / 11期

基金：

加拿大自然科学与工程研究理事会;

关键词：

AVIAN INFLUENZA-VIRUSES; SMALL ANIMAL-MODEL; SYRIAN-HAMSTERS; HIGH-TITER; COVID-19; IMMUNIZATION; REQUIREMENT; PRIMATES; ANTIGEN; CELLS;

D O I：

10.1016/j.isci.2021.103219

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

The pandemic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of coronavirus disease 2019 (COVID-19). Worldwide efforts are being made to develop vaccines to mitigate this pandemic. We engineered two recombinant Newcastle disease virus (NDV) vectors expressing either the full-length SARS-CoV-2 spike protein (NDV-FLS) or a version with a 19 amino acid deletion at the carboxy terminus (NDV-Delta 19S). Hamsters receiving two doses (prime-boost) of NDV-FLS developed a robust SARS-CoV-2-neutralizing antibody response, with elimination of infectious virus in the lungs and minimal lung pathology at five days post-challenge. Single-dose vaccination with NDV-FLS significantly reduced SARS-CoV-2 replication in the lungs but only mildly decreased lung inflammation. NDV-Delta 19S-treated hamsters had a moderate decrease in SARS-CoV-2 titers in lungs and presented with severe microscopic lesions, suggesting that truncation of the spike protein was a less effective strategy. In summary, NDV-vectored vaccines represent a viable option for protection against COVID-19.

引用

页数：28

共 50 条

[1] A single intranasal dose of a live-attenuated parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in hamsters [J].

Liu, Xueqiao ;

Luongo, Cindy ;

Matsuoka, Yumiko ;

Park, Hong-Su ;

Santos, Celia ;

Yang, Lijuan ;

Moore, Ian N. ;

Afroz, Sharmin ;

Johnson, Reed F. ;

Lafont, Bernard A. P. ;

Martens, Craig ;

Best, Sonja M. ;

Munster, Vincent J. ;

Holly, Jaroslav ;

Yewdell, Jonathan W. ;

Le Nouen, Cyril ;

Munir, Shirin ;

Buchholz, Ursula J. .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (50)

[2] An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters [J].

Deng, Shaofeng ;

Liu, Ying ;

Tam, Rachel Chun-Yee ;

Chen, Pin ;

Zhang, Anna Jinxia ;

Mok, Bobo Wing-Yee ;

Long, Teng ;

Kukic, Anja ;

Zhou, Runhong ;

Xu, Haoran ;

Song, Wenjun ;

Chan, Jasper Fuk-Woo ;

To, Kelvin Kai-Wang ;

Chen, Zhiwei ;

Yuen, Kwok-Yung ;

Wang, Pui ;

Chen, Honglin .

NATURE COMMUNICATIONS, 2023, 14 (01)

[3] Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys [J].

Le Nouen, Cyril ;

Nelson, Christine E. ;

Liu, Xueqiao ;

Park, Hong-Su ;

Matsuoka, Yumiko ;

Luongo, Cindy ;

Santos, Celia ;

Yang, Lijuan ;

Herbert, Richard ;

Castens, Ashley ;

Moore, Ian N. ;

Wilder-Kofie, Temeri ;

Moore, Rashida ;

Walker, April ;

Zhang, Peng ;

Lusso, Paolo ;

Johnson, Reed F. ;

Garza, Nicole L. ;

Via, Laura E. ;

Munir, Shirin ;

Barber, Daniel L. ;

Buchholz, Ursula J. .

CELL, 2022, 185 (25) :4811-+

[4] Newcastle Disease Virus as a Vaccine Vector for SARS-CoV-2 [J].

Shirvani, Edris ;

Samal, Siba K. .

PATHOGENS, 2020, 9 (08) :1-8

[5] Mucosal Vaccination with a Newcastle Disease Virus-Vectored Vaccine Reduces Viral Loads in SARS-CoV-2-Infected Cynomolgus Macaques [J].

Warner, Bryce M. ;

Chan, Mable ;

Tailor, Nikesh ;

Vendramelli, Robert ;

Audet, Jonathan ;

Meilleur, Courtney ;

Truong, Thang ;

Garnett, Lauren ;

Willman, Marnie ;

Soule, Geoff ;

Tierney, Kevin ;

Albietz, Alixandra ;

Moffat, Estella ;

Higgins, Rick ;

Santry, Lisa A. ;

Leacy, Alexander ;

Pham, Phuc H. ;

Yates, Jacob G. E. ;

Pei, Yanlong ;

Safronetz, David ;

Strong, James E. ;

Susta, Leonardo ;

Embury-Hyatt, Carissa ;

Wootton, Sarah K. ;

Kobasa, Darwyn .

VACCINES, 2024, 12 (04)

[6] LSDV-Vectored SARS-CoV-2 S and N Vaccine Protects against Severe Clinical Disease in Hamsters [J].

de Moor, Warren R. J. ;

Williamson, Anna-Lise ;

Schafer, Georgia ;

Douglass, Nicola ;

Gers, Sophette ;

Sutherland, Andrew D. ;

Blumenthal, Melissa J. ;

Margolin, Emmanuel ;

Shaw, Megan L. ;

Preiser, Wolfgang ;

Chapman, Rosamund .

VIRUSES-BASEL, 2023, 15 (07)

[7] Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental challenge infection in hamsters [J].

de Swart, Rik L. ;

de Leeuw, Olav S. ;

Oreshkova, Nadia ;

Gerhards, Nora M. ;

Albulescu, Irina C. ;

Vreman, Sandra ;

Gonzales, Jose L. ;

Maas, Riks ;

van Kuppeveld, Frank J. M. ;

Soema, Peter ;

Bosch, Berend-Jan ;

Peeters, Ben P. H. .

VACCINE, 2022, 40 (33) :4676-4681

[8] Intranasal Administration of Recombinant Newcastle Disease Virus Expressing SARS-CoV-2 Spike Protein Protects hACE2 TG Mice against Lethal SARS-CoV-2 Infection [J].

Kim, Deok-Hwan ;

Lee, Jiho ;

Lee, Da-Ye ;

Lee, Seung-Hun ;

Jeong, Jei-Hyun ;

Kim, Ji-Yun ;

Kim, Jiwon ;

Choi, Yang-Kyu ;

Lee, Joong-Bok ;

Park, Seung-Young ;

Choi, In-Soo ;

Lee, Sang-Won ;

Youk, Sungsu ;

Song, Chang-Seon .

VACCINES, 2024, 12 (08)

[9] Intranasal administration of convalescent plasma protects against SARS-CoV-2 infection in hamsters [J].

Wouters, Elise ;

Verbrugghe, Caro ;

Abdelnabi, Rana ;

Devloo, Rosalie ;

De Clippel, Dorien ;

Jochmans, Dirk ;

De Bleser, Dominique ;

Weynand, Birgit ;

Compernolle, Veerle ;

Neyts, Johan ;

Feys, Hendrik B. .

EBIOMEDICINE, 2023, 92

[10] Intranasal parainfluenza virus-vectored vaccine expressing SARS-CoV-2 spike protein of Delta or Omicron B.1.1.529 induces mucosal and systemic immunity and protects hamsters against homologous and heterologous challenge [J].

Park, Hong-Su ;

Matsuoka, Yumiko ;

Santos, Celia ;

Luongo, Cindy ;

Liu, Xueqiao ;

Yang, Lijuan ;

Kaiser, Jaclyn A. ;

Duncan, Eleanor F. ;

Johnson, Reed F. ;

Teng, I-Ting ;

Kwong, Peter D. ;

Buchholz, Ursula J. ;

Le Nouen, Cyril .

PLOS PATHOGENS, 2025, 21 (04)

← 1 2 3 4 5 →